TATSUAKI SUMIYOSHI

Last Updated :2024/05/07

Affiliations, Positions
Graduate School of Biomedical and Health Sciences(Medical), Assistant Professor
E-mail
tasu0505hiroshima-u.ac.jp

Basic Information

Major Professional Backgrounds

  • 2000/05, 2001/03, Hiroshima University, Hospital, Clinical Resident
  • 2001/04, 2004/03, Hiroshima City Asa Citizens Hospital, Clinical Resident
  • 2004/04, 2005/09, Kure Kyosai Hospital, Doctor
  • 2005/10, 2007/09, St.Luke`s International Hospital, Doctor
  • 2007/10, 2008/03, Kure Kyosai Hospital, Doctor
  • 2008/04, 2011/03, Shizuoka Cancer Center, Doctor
  • 2011/04, 2019/03, Kochi Health Sciences Center, Doctor
  • 2019/04, 2020/03, Kure Kyosai Hospital, Doctor
  • 2020/04/01, 2022/03/31, Hiroshima University, Hospital, Assistant Professor
  • 2022/04/01, Hiroshima University, Graduate School of Biomedical and Health Sciences, Assistant Professor

Educational Backgrounds

  • Hiroshima University, Graduate School of Biomedical and Health Sciences, Japan, 2008/04, 2013/03
  • Hiroshima University, School of Medicine , Japan, 1994/04, 2000/03

Academic Degrees

  • Hiroshima University

Educational Activity

  • [Bachelor Degree Program] School of Medicine : Program of Medicine : Medicine
  • [Master's Program] Graduate School of Biomedical and Health Sciences : Division of Integrated Health Sciences
  • [Doctoral Program] Graduate School of Biomedical and Health Sciences : Division of Biomedical Sciences : Program of Medicine

Research Fields

  • Medicine,dentistry, and pharmacy;Clinical surgery;Digestive surgery

Educational Activity

Course in Charge

  1. 2024, Undergraduate Education, Intensive, Introduction to clinical clerkship
  2. 2024, Undergraduate Education, Intensive, Practice of Medicine I
  3. 2024, Undergraduate Education, First Semester, Surgery I

Research Activities

Academic Papers

  1. Pathologic complete response following FOLFIRINOX and olaparib treatment for hepatic metastasized pancreatic ductal adenocarcinoma with a germline BRCA mutation, CLINICAL JOURNAL OF GASTROENTEROLOGY, 16(2), 283-288, 202304
  2. Identification of Preoperative Risk Factors for Poor Survival in Patients with Resectable Pancreatic Cancer Treated with Upfront Surgery, DIGESTIVE SURGERY, 38(5-6), 352-360, 2021
  3. Hepatic artery resection in distal cholangiocarcinoma, LANGENBECKS ARCHIVES OF SURGERY, 408(1), 20230123
  4. Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated with surgical resection and perioperative chemotherapy, PANCREATOLOGY, 22(4), 479-487, 202205
  5. A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy, CLINICAL JOURNAL OF GASTROENTEROLOGY, 15(6), 1164-1168, 202212
  6. Clinicopathological features of gastric cancer after pancreaticoduodenectomy: reporting of three institutional cases and review of the global literature, LANGENBECKS ARCHIVES OF SURGERY, 407(6), 2259-2271, 202209
  7. Mesenteric approach in pancreas-preserving partial duodenectomy for aortic graft-duodenal fistula: a case report, CLINICAL JOURNAL OF GASTROENTEROLOGY, 15(5), 920-923, 202210
  8. Optimal lymph-node dissection for pancreatic tail cancer, SURGERY TODAY, 52(9), 1307-1312, 202209
  9. Prognosis following an extended duration of adjuvant gemcitabine plus S-1 chemotherapy in patients with pancreatic ductal adenocarcinoma: Analysis using inverse probability of treatment weighting, JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 29(8), 911-921, 202208
  10. Cancer Res, 2001
  11. Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer., Oncogene, 1999
  12. Preoperative risk factors for positivity of peritoneal lavage cytology in patients with pancreatic ductal adenocarcinoma in the era of neoadjuvant therapy, PANCREATOLOGY, 22(5), 583-589, 202206
  13. Long-term survival after distal pancreatectomy with celiac axis resection and hepatic artery reconstruction in the setting of locally advanced unresectable pancreatic cancer, CLINICAL JOURNAL OF GASTROENTEROLOGY, 15(3), 635-641, 202206
  14. Neoadjuvant therapy contributes to nodal downstaging of pancreatic cancer, LANGENBECKS ARCHIVES OF SURGERY, 407(2), 623-632, 202203
  15. A phase II study of gemcitabine/nab-paclitaxel/S-1 combination neoadjuvant chemotherapy for patients with borderline resectable pancreatic cancer with arterial contact, EUROPEAN JOURNAL OF CANCER, 159, 215-223, 202112
  16. Increased clostridium difficile infection in the era of preoperative chemotherapy for pancreatic cancer, PANCREATOLOGY, 22(2), 258-263, 202203
  17. Liver-specific contrast agent-enhanced magnetic resonance and F-18-fluorodeoxyglucose positron emission tomography findings of hepatocellular adenoma: report of a case, SURGERY TODAY, 42(2), 200-204, 2012
  18. Synchronous double cancers of the common bile duct, WORLD JOURNAL OF GASTROENTEROLOGY, 18(41), 5982-5985, 2012
  19. Diagnosis and management of insulinoma, WORLD JOURNAL OF GASTROENTEROLOGY, 19(6), 829-837, 2013
  20. Necrotic Hepatocellular Carcinoma Occurring within an Inflammatory Pseudotumor-like Nodule, INTERNAL MEDICINE, 52(5), 551-554, 2013
  21. CT/Tc-99m-GSA SPECT fusion images demonstrate functional differences between the liver lobes, WORLD JOURNAL OF GASTROENTEROLOGY, 19(21), 3217-3225, 2013
  22. Comparison of pancreatic acinar cell carcinoma and adenocarcinoma using multidetector-row computed tomography, WORLD JOURNAL OF GASTROENTEROLOGY, 19(34), 5713-5719, 2013
  23. Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN, ONCOLOGY LETTERS, 5(6), 1819-1825, 2013
  24. Endovascular pseudoaneurysm repair after distal pancreatectomy with celiac axis resection, WORLD JOURNAL OF GASTROENTEROLOGY, 19(45), 8435-8439, 2013
  25. Primary Liposarcoma of the Duodenum: A First Case Presentation, INTERNAL MEDICINE, 52(24), 2753-2757, 2013
  26. Extrahepatic stem cells mobilized from the bone marrow by the supplementation of branched- chain amino acids ameliorate liver regeneration in an animal model, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29(4), 870-877, 2014
  27. Needle tract implantation of hepatoblastoma after percutaneous needle biopsy: report of a case, SURGERY TODAY, 44(6), 1138-1141, 2014
  28. Surgical outcomes for 131 cases of carcinosarcoma of the hepatobiliary tract, JOURNAL OF GASTROENTEROLOGY, 49(6), 982-991, 2014
  29. Intensive Versus Intermediate Glucose Control in Surgical Intensive Care Unit Patients, DIABETES CARE, 37(6), 1516-1524, 2014
  30. S-1 vs. Gemcitabine as an Adjuvant Therapy after Surgical Resection for Ductal Adenocarcinoma of the Pancreas, WORLD JOURNAL OF SURGERY, 38(11), 2986-2993, 2014
  31. ★, Functional Discrepancy between Two Liver Lobes after Hemilobe Biliary Drainage in Patients with Jaundice and Bile Duct Cancer: An Appraisal Using Tc-99m-GSA SPECT/CT Fusion Imaging, RADIOLOGY, 273(2), 444-451, 2014
  32. Heterotopic Pancreas in the Common Bile Duct, with a Review of the Literature, INTERNAL MEDICINE, 53(23), 2679-2682, 2014
  33. Long-Term Survival Following Pancreatectomy and S-1 Chemotherapy for Pancreatic Acinar Cell Carcinoma With Peritoneal Dissemination A Case Report and Literature Review, MEDICINE, 94(1), 2015
  34. Rapid shrinkage of a pancreatic serous cystadenoma with cystic degeneration: report of a case, SURGERY TODAY, 45(5), 647-651, 2015
  35. Reconsideration about the aggressive surgery for resectable pancreatic cancer: a focus on real pathological portosplenomesenteric venous invasion, LANGENBECKS ARCHIVES OF SURGERY, 400(4), 487-494, 2015
  36. Desmoid tumor of the stomach, ENDOSCOPY, 47, E242-E243, 2015
  37. Completion pancreatectomy for recurrent pancreatic cancer in the remnant pancreas: report of six cases and a review of the literature, LANGENBECKS ARCHIVES OF SURGERY, 400(8), 973-978, 2015
  38. Short-term Outcomes of Hand-sewn Stump Closure after Distal Pancreatectomy at a Single Institution, AMERICAN SURGEON, 82(3), E60-E62, 2016
  39. Surgical Management in Patients with Gastrointestinal Stromal Tumors: A Single-Center Experience, ONCOLOGY, 90(5), 273-279, 2016
  40. Clinicopathological features and surgical outcomes of intraductal tubulopapillary neoplasm of the pancreas: a systematic review, LANGENBECKS ARCHIVES OF SURGERY, 401(4), 439-447, 2016
  41. Liver function assessment using 99mTc-GSA single-photon emission computed tomography (SPELT)/CT fusion imaging in hilar bile duct cancer: A retrospective study, SURGERY, 160(1), 118-126, 2016
  42. Is a surgical approach justified for octogenarians with pancreatic carcinoma? Projecting surgical decision making for octogenarian patients, AMERICAN JOURNAL OF SURGERY, 212(5), 896-902, 2016
  43. Clinical effects of chemoradiotherapy toward optimal treatment of locally advanced unresectable pancreatic cancer, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31, 259-259, 2016
  44. Surgical management in patients with gastrointestinal stromal tumors: A single center experience, JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 31, 436-436, 2016
  45. Adenomyomatosis Concomitant with Primary Gallbladder Carcinoma, ACTA MEDICA OKAYAMA, 71(2), 113-118, 2017
  46. Clinical effects of chemoradiotherapy in pursuit of optimal treatment of locally advanced unresectable pancreatic cancer, BRITISH JOURNAL OF RADIOLOGY, 90(1075), 2017
  47. Multidetector CT in detection of troublesome posterior sectoral hepatic duct communicating with cystic duct, BRITISH JOURNAL OF RADIOLOGY, 90(1078), 2017
  48. A novel utility of Tc-99m-GSA SPECT/CT fusion imaging: detection of inadequate portal vein embolization, JAPANESE JOURNAL OF RADIOLOGY, 35(12), 748-754, 2017
  49. Liver Function Assessment Using Technetium 99m-Galactosyl Single-Photon Emission Computed Tomography/CT Fusion Imaging: A Prospective Trial, JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 225(6), 789-797, 2017
  50. Characterization of Prognostic Factors and the Efficacy of Adjuvant S-1 Chemotherapy in Patients with Post-surgery Extrahepatic Bile Duct Cancer, ANTICANCER RESEARCH, 37(12), 7049-7056, 2017
  51. Incidence and Risk Factors of Cholangitis after Hepaticojejunostomy, JOURNAL OF GASTROINTESTINAL SURGERY, 22(4), 676-683, 2018
  52. Correlation between the skeletal muscle index and surgical outcomes of pancreaticoduodenectomy, SURGERY TODAY, 48(5), 545-551, 2018
  53. A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic Cancer, ANNALS OF SURGICAL ONCOLOGY, 25(7), 1889-1895, 2018
  54. Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma, WORLD JOURNAL OF SURGERY, 42(9), 2910-2918, 2018
  55. Tc-99m-GSA SPECT/CT fusion imaging for hepatectomy candidates with extremely deteriorated ICG value, JAPANESE JOURNAL OF RADIOLOGY, 36(9), 537-543, 2018
  56. Liver fibrosis assessment using 99mTc-GSA SPECT/CT fusion imaging, JAPANESE JOURNAL OF RADIOLOGY, 37(4), 315-320, 2019
  57. Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma, PANCREATOLOGY, 20(7), 1472-1478, 202010
  58. New surgical technique for pancreatic lithotripsy without coring-out, CLINICAL JOURNAL OF GASTROENTEROLOGY, 13(6), 1343-1346, 202012
  59. Falciform ligament hernia with specific abdominal symptom, CLINICAL JOURNAL OF GASTROENTEROLOGY, 14(2), 566-569, 202104
  60. Prognostic significance of dissecting the nerve plexus around the common hepatic artery in pancreatic cancer, LANGENBECKS ARCHIVES OF SURGERY, 406(3), 679-689, 202105
  61. Preoperative risk factors for para-aortic lymph node positivity in pancreatic cancer, PANCREATOLOGY, 21(3), 606-612, 202104
  62. The prognostic impact of peritoneal washing cytology for otherwise resectable extrahepatic cholangiocarcinoma patients, SURGERY TODAY, 51(7), 1227-1231, 202107
  63. Is surgery justified for elderly patients with extrahepatic cholangiocarcinoma? Reappraisal from a viewpoint of comorbidity and organ function, SURGERY TODAY, 51(11), 1787-1794, 202111
  64. Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Resectability Status, JOURNAL OF GASTROINTESTINAL SURGERY, 25(11), 2871-2880, 202111

Invited Lecture, Oral Presentation, Poster Presentation

  1. Clinical Implications of Pre- and Postoperative Circulating Tumor DNA in Patients with Resected Pancreatic Ductal Adenocarcinoma, Tatsuaki Sumiyoshi, 2022, Without Invitation, English, published
  2. Is the clostridium difficile infection increased by preoperative chemotherapy in patients with pancreatic cancer?, Tatsuaki Sumiyoshi, 2021/06/02, Without Invitation, English, published

Social Activities

History as Peer Reviews of Academic Papers

  1. 2022, HPB, Others, 1
  2. 2022, Digestive Surgery, Others, 1
  3. 2020, HPB, Editor, 1